Fractyl Health, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Fractyl Health, Inc. (GUTS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $28.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-24
- Fractyl Health, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $28.36M, a 20.23% increase from fiscal 2024.
- Fractyl Health, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $23.58M, a 59.07% increase from fiscal 2023.
- Fractyl Health, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $14.83M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $28.36M 10-K · filed 2026-03-24 |
| 2024-12-31 | $23.58M 10-K · filed 2026-03-24 |
| 2023-12-31 | $14.83M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |